Page 5 - Son Pfizer News Today : Breaking News, Live Updates & Top Stories | Vimarsana

First booster shots for the general public will go into arms september 20th after the fda and cdc sign off, most adults fully vaccinated for at least eight months will qualify a top priority, protecting health care workers, nursing home residents, and seniors who were vaccinated first. the booster shot, a third dose of the same formula and vaccine for those who were fully inoculated with pfizer or moderna. >> it will be easy just show your vaccination card, you'll get a booster. >> reporter: for those vaccinated with johnson & johnson, a booster will likely be needed but for now there's simply...

There's going to be a need for a third shot in the coming months? >> so i think at some point down the road we will likely need a third shot. is that moment today? no. and when scott gottlieb says we missed the boat on the delta variant, we've missed the boat in getting the other 40% of americans vaccinated, not in whether or not we've gotten them a third shot. those two shots at pfizer or moderna work so well. i appreciate pfizer bringing it forward, but i am fully on the side of cdc and fda here, which is every piece of data that we have right now says that a booster is not needed today. mig...

Most people fully recover, and the risk is remote. but will you say that the concern had to be serious enough in order for the cdc and fda to even announce this investigation? >> so, for them to announce this investigation, means that they think that there is a plausible link. it shows once again how carefully we take the safety of vaccines in this country that when there are enough reports of a condition linked to a vaccine, we look into it. now even if it ends up being real, it's still fewer than one in a million vaccine doses that end up with this syndrome. and there are around 3,000 to 5,0...

Towards getting children protected. scott, what can you tell us about these new efforts to get kids protected? >> reporter: hey, robyn, yeah. so the eu is following the lead of the united states and canada in approving the pfizer/biontech vaccine for children as young as 12 years old. the european vaccines regulator said that shot was just as or more effective as it was in older teenagers or young adults with roughly more or less the same kind of side effects. the regulator also conceded that the side of the clinical trial that was used to approve this vaccine wasn't big enough to pick up any ...

Number could be as low as 75%. pfizer is also working on a clinical trial with data expected in september -- or by september on kids as young as 6 months old. so this process of getting younger and younger really is continuing. but europe before it even thinks about starting to vaccinate kids really needs to pick up the pace when it comes to the adult population. you mentioned the numbers when it comes to europe-wide vaccinations. more than one-third of the population has gotten at least one shot, so at least that's good. but that still lags well behind countries like the u.s. and the uk. the ...